Related Experiment Video
Updated: Sep 28, 2025

Efficient Gene Knockdown in the Liver via Intrasplenic Injection of Adeno-Associated Virus Serotype 8 (AAV8)-Delivered Small Hairpin RNA
Published on: November 1, 2024
Spliceostatin A stabilizes CDKN1B mRNA through the 3' UTR
1Graduate School of Medicine and Pharmaceutical Sciences, University of Toyama, 2630 Sugitani, Toyama, 930-0194, Japan.
Abstract:
Pre-mRNA splicing is one of the most important mechanisms in gene expression in eukaryotes, and therefore splicing inhibition affects various cellular functions. We previously reported that the potent splicing inhibitor spliceostatin A (SSA) causes cell cycle arrest at G1 and G2/M phases. Upregulation of the p27 cyclin dependent kinase inhibitor, encoded by the CDKN1B gene, is one of the reasons for G1 phase arrest caused by SSA treatment. However, the molecular mechanism of p27 upregulation by SSA remains unknown. In this study, we found that SSA treatment caused stabilization of the p27 protein and increase of CDKN1B mRNA. SSA did not affect transcription of CDKN1B gene, but stabilized CDKN1B mRNA. Finally, we revealed that the 3' untranslated region of CDKN1B mRNA was involved in the stabilization. These results suggest that stabilization of CDKN1B mRNA is one of the reasons of upregulation of the p27 protein by SSA.
Insights
Spliceostatin A (SSA) upregulates p27 protein by stabilizing CDKN1B mRNA, not affecting transcription. The 3' untranslated region of CDKN1B mRNA is key to this post-transcriptional regulation.
Area of Science:
- Molecular Biology
- Gene Expression Regulation
- Cell Cycle Control
Background:
- Pre-mRNA splicing is crucial for eukaryotic gene expression; splicing inhibitors impact cellular functions.
- Spliceostatin A (SSA), a potent splicing inhibitor, induces cell cycle arrest at G1 and G2/M phases.
- SSA treatment leads to p27 protein upregulation, contributing to G1 phase arrest, but the mechanism is unclear.
Purpose of the Study:
- To elucidate the molecular mechanism behind p27 protein upregulation induced by SSA.
- To investigate the effect of SSA on CDKN1B gene expression at transcriptional and post-transcriptional levels.
- To identify the specific mRNA regions involved in SSA-mediated regulation.
Main Methods:
- Analysis of p27 protein levels and CDKN1B mRNA expression following SSA treatment.
- Assessment of CDKN1B gene transcription rates.
- Investigation of mRNA stability, focusing on the 3' untranslated region (3' UTR).
Main Results:
- SSA treatment resulted in p27 protein stabilization and increased CDKN1B mRNA levels.
- SSA did not alter CDKN1B gene transcription but enhanced CDKN1B mRNA stability.
- The 3' UTR of CDKN1B mRNA was identified as a critical element in SSA-induced mRNA stabilization.
Conclusions:
- SSA upregulates p27 protein primarily through the stabilization of CDKN1B mRNA.
- This post-transcriptional regulation mechanism involves the 3' untranslated region of CDKN1B mRNA.
- Understanding this pathway provides insights into splicing inhibitor effects on gene expression and cell cycle control.
Related Concept Videos
RNA Stability
mRNA Stability and Gene Expression
Cis-acting Elements involved in mRNA stability
Nonsense-mediated mRNA Decay
Usually, Upf3 binds to an Exon Junction Complex (EJC) at mRNA splice sites. If a ribosome fully translates the mRNA,...
Nuclear Export of mRNA
Regulation of Expression at Multiple Steps
Anaphase Promoting Complex

